Literature DB >> 18303930

Modification of the Stöber process by a polyazamacrocycle leading to unusual core-shell silica nanoparticles.

Sylvie Masse1, Guillaume Laurent, Françoise Chuburu, Cyril Cadiou, Isabelle Déchamps, Thibaud Coradin.   

Abstract

In the view of designing functional nanoparticles, the encapsulation of 1,4,7,10-tetraazacyclododecane (cyclen) within silica nanoparticles using the Stöber process was studied. In the presence of cyclen and tetraethoxysilane (TEOS), silica particles exhibiting an unusual core-shell structure were obtained. On then basis of TEM, DLS, and NMR data, we suggest that the particle core is constituted of hybrid primary nanoparticles resulting from cyclen-silica interactions, whereas the shell formation results from further condensation of unreacted silica precursors. Control experiments performed with the zinc-cyclen complex and ammonia addition suggest that cyclen-TEOS interactions arise from the activation of the silicon alkoxide hydrolysis with the polyazamacrocycle amine groups. These data are discussed in the context of silica biomineralization mechanisms, where polyamine/silica interactions have been shown to play a major role. Moreover, the possibility to control the size and the structure of these nanoparticles makes them promising materials for pharmaceutical applications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18303930     DOI: 10.1021/la703828v

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  2 in total

Review 1.  Silaffins in Silica Biomineralization and Biomimetic Silica Precipitation.

Authors:  Carolin C Lechner; Christian F W Becker
Journal:  Mar Drugs       Date:  2015-08-19       Impact factor: 5.118

2.  Synthesis of Silica-coated Iron Oxide Nanoparticles: Preventing Aggregation without Using Additives or Seed Pretreatment.

Authors:  Zeinab Sharafi; Bita Bakhshi; Jaber Javidi; Sina Adrangi
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.